Two common medications that are categorized as blood thinners and used to prevent blood clots are anticoagulants and antiplatelets. Both are essential in treating conditions caused by blood clots ...

Oral anticoagulant or antiplatelet medication use had no substantial effect on the accuracy of multitarget stool DNA testing for colorectal cancer, according to a study published in Gastro Hep ...

Anticoagulants and antiplatelet agents pose a great risk in patients undergoing surgery. Because these products inhibit at least one, and often multiple, factors in the clotting cascade ...

Overall, triple antithrombotic therapy with the addition of warfarin to dual antiplatelet therapy did not reduce the risk of reinfarction in patients undergoing primary PCI and did increase the ...

Clinically significant reductions in bleeding underscore abelacimab’s strong potential to address an unmet need for patients ...

Aplagon, a clinical stage biopharmaceutical company developing a first-in-class therapeutic for thrombo-inflammatory diseases, known as APAC, a heparin proteoglycan mimetic with antiplatelet and ...